Adults taking a high antihistamine dose vs. placebo before endurance exercise training sessions had less improvement in peak ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

The In re Zantac (Ranitidine) Litigation appeal provides the First State's high court a prime opportunity to clarify Delaware law on those two issues and remind trial judges that in most instances ...

A Florida State Court sided with GSK, dismissing expert testimonies that linked ranitidine to prostate cancer, reflecting a broader scientific consensus that there is no consistent evidence ...

GSK GSK issued a statement disagreeing with the ruling by a state court in Delaware to allow jury trials for cases, which claim GSK’s discontinued heartburn drug Zantac (ranitidine) causes ...

While acknowledging that ranitidine can degrade into NDMA, Hobbiger repeatedly pushed back on the claim that Zantac causes cancer.